Eric W. Sankey

Neuroscience · Life Sciences

28h-index2.8kcitations132works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cerebrospinal fluid and hydrocephalus(26), Spine and Intervertebral Disc Pathology(25), Glioma Diagnosis and Treatment(19), Spinal Fractures and Fixation Techniques(17), Management of metastatic bone disease(16)

Publications131 total

1338 Automated Volumetric Segmentation Enables Post-Laser Interstitial Thermal Therapy Response Assessment
Neurosurgery·2025
NIMG-05. ARTIFICIAL INTELLIGENCE-BASED RESPONSE ASSESSMENT FOR PATIENTS RECEIVING LASER INTERSTITIAL THERMAL THERAPY
Neuro-Oncology·2024· 1 citedOpen Access
NIRL-01 DEEP LEARNING-BASED VOLUMETRIC SEGMENTATION ENABLES RESPONSE ASSESSMENT AFTER LASER INTERSTITIAL THERMAL THERAPY
Neuro-Oncology Advances·2024Open Access
Ultrasound inhibits tumor growth and selectively eliminates malignant brain tumor in vivo
Bioengineering & Translational Medicine·2024· 3 citedOpen Access
Author response for "Ultrasound inhibits tumor growth and selectively eliminates malignant brain tumor in vivo"
2024
Preoperative validation of edema-corrected tractography in neurosurgical practice: translating surgeon insights into novel software implementation
Frontiers in Neurology·2024· 4 citedOpen Access
Brain Metastases: Molecules to Medicine
Cambridge University Press eBooks·2024
Automated segmentation of ablated lesions using deep convolutional neural networks: A basis for response assessment following laser interstitial thermal therapy
Neuro-Oncology·2024· 7 citedOpen Access
Breast‐to‐brain metastasis is exacerbated with chemotherapy through blood–cerebrospinal fluid barrier and induces Alzheimer's‐like pathology
Journal of Neuroscience Research·2023· 12 citedOpen Access
Antibodies from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Data from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
TIM-3 expression on lymphocytes from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Antibodies from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Lymphocyte gating strategy. from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Gating strategy for APC characterization from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Lymphocyte gating strategy. from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
TIM-3 expression on lymphocytes from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Stereotactic radiation with SARRP delivery system from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Data from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
Stereotactic radiation with SARRP delivery system from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
2023Open Access
page 1 of 7Next →

Frequent Co-authors

C. Rory Goodwin(26), Daniel M. Sciubba(14), Ann Liu(11), Ignacio Jusué-Torres(9), Benjamin D. Elder(9), Vikram A. Mehta(8), Daniele Rigamonti(8), Ali Bydon(7), Timothy F. Witham(7), Jean‐Paul Wolinsky(7), Ziya L. Gokaslan(7), Isaac O. Karikari(7), Timothy Y. Wang(7), Henry Brem(6), Peter E. Fecci(6), Nancy Abu-Bonsrah(6), Jennifer Lu(6), Muhammad M. Abd‐El‐Barr(6), Thomas Kosztowski(6), Antonella Mangraviti(5)